Economics
Glaxo Executive Unable to Leave China Amid Probe
This article is for subscribers only.
GlaxoSmithKline Plc’s finance chief in China is unable to leave the country as local authorities investigate allegations of economic crimes at the maker of the world’s top-selling drug.
The travel restriction was imposed at the end of June, Simon Steel, a Glaxo spokesman in London, said yesterday by phone. Steve Nechelput, the executive, hasn’t been questioned or arrested and isn’t being detained, he said. The British embassy is providing the British national with consular assistance, John Gallagher, a Beijing-based spokesman, said by phone.